PHF13 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL23682845	1.00	1/20
SCHEMBL12592289	0.80	1/20
SCHEMBL19688299	0.67	1/20
SCHEMBL22753440	0.67	1/20
SCHEMBL7052409	0.66	1/20
SCHEMBL14006003	0.64	1/20
SCHEMBL6393265	0.62	1/20
SCHEMBL7056252	0.61	1/20
SCHEMBL16964068	0.61	1/20
SCHEMBL29817956	0.61	1/20
Hydrochloric Acid (SCHEMBL7058792)	0.60	1/20
SCHEMBL16964662	0.60	1/20
SCHEMBL30444255	0.59	1/20
SCHEMBL6361404	0.58	1/20
SCHEMBL15228268	0.58	1/20
SCHEMBL31533961	0.58	1/20
SCHEMBL23717941	0.58	1/20
SCHEMBL7055489	0.58	1/20
SCHEMBL1135063	0.57	1/20
SCHEMBL17873924	0.57	1/20

Clinical trials — most relevant to PHF13 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients	PHASE4	NOT_YET_RECRUITING
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia	PHASE3	COMPLETED
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia	PHASE3	ACTIVE_NOT_RECRUITING
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia	PHASE3	COMPLETED
Study in Adult Ph-positive ALL	PHASE2	UNKNOWN
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer	PHASE2	COMPLETED
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure	PHASE2	COMPLETED
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma	PHASE2	WITHDRAWN
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers	PHASE2	NOT_YET_RECRUITING
Phase II Study of Vandetanib in Individuals With Kidney Cancer	PHASE2	COMPLETED
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)	PHASE1	NOT_YET_RECRUITING
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia	nan	UNKNOWN
Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy	nan	UNKNOWN
Characterizing a 5P-Linked BHR Susceptibility Locus	nan	COMPLETED
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia	nan	COMPLETED
Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma	nan	COMPLETED
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus	nan	ACTIVE_NOT_RECRUITING
Epithelioid Haemangioendothelioma Observational Study	nan	RECRUITING
Study of Proteins in Head and Neck Cancer Cells	nan	COMPLETED
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Clinical Implication of Bone Marrow Perfusion Patterns Imaged by Dynamic MRI in Multiple Myeloma	nan	UNKNOWN
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies	nan	WITHDRAWN
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis.	nan	COMPLETED
Identification of an Asthma Susceptibility Gene on 3P	nan	COMPLETED
Clinical and Genomic Registry of MDS in Asia	nan	UNKNOWN
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors	nan	UNKNOWN
A Study of the Genetic Analysis of Brain Disorders	nan	COMPLETED
Association of Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer in Egyptian Population	nan	COMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis	nan	UNKNOWN
H19 in Acute Lymphoblastic Leukemia.	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a PHF13 binder may also engage these)

Protein	Name	Similarity
Q8K2W6	—	1.000	Q8K2W6 →
Q5XJV7	—	0.980	Q5XJV7 →
Q6ZNC4	—	0.980	Q6ZNC4 →
F7AQ22	—	0.980	F7AQ22 →
Q6AI12	—	0.978	Q6AI12 →
P97432	—	0.978	P97432 →
P49140	—	0.978	P49140 →
Q501R9	—	0.978	Q501R9 →
A0A1L8GR68	—	0.977	A0A1L8GR68 →
P0C6S7	—	0.977	P0C6S7 →
B3KU38	—	0.977	B3KU38 →
Q9WU42	—	0.976	Q9WU42 →
Q5SUE8	—	0.976	Q5SUE8 →
Q8BIZ1	—	0.976	Q8BIZ1 →
P24793	—	0.976	P24793 →
Q96N64	—	0.976	Q96N64 →
Q80YE2	—	0.975	Q80YE2 →
Q8QFX1	—	0.975	Q8QFX1 →
P78524	—	0.975	P78524 →
Q9C0A6	—	0.975	Q9C0A6 →
A4FV61	—	0.975	A4FV61 →
P12755	—	0.975	P12755 →
Q1LY51	—	0.974	Q1LY51 →
Q62511	—	0.974	Q62511 →
Q60698	—	0.974	Q60698 →
A0A088MLT8	—	0.974	A0A088MLT8 →
P0DPB3	—	0.974	P0DPB3 →
Q69Z61	—	0.974	Q69Z61 →
Q9WTU0	—	0.974	Q9WTU0 →
Q8NBZ0	—	0.974	Q8NBZ0 →